PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | +33.3% | 6,500 | +47.7% | 0.00% | – |
| Q1 2017 | $3,000 | +200.0% | 4,400 | -23.9% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 5,779 | +25.6% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 4,600 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 4,600 | -47.2% | 0.00% | – |
| Q1 2016 | $4,000 | -60.0% | 8,715 | -0.5% | 0.00% | – |
| Q4 2015 | $10,000 | -92.7% | 8,763 | -93.5% | 0.00% | – |
| Q3 2015 | $137,000 | -72.4% | 134,500 | -64.6% | 0.00% | – |
| Q2 2015 | $497,000 | -0.2% | 380,017 | +3.0% | 0.00% | – |
| Q1 2015 | $498,000 | +8200.0% | 368,849 | +8188.7% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 4,450 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -25.0% | 4,450 | 0.0% | 0.00% | – |
| Q2 2014 | $8,000 | 0.0% | 4,450 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | +33.3% | 4,450 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 4,450 | -6.1% | 0.00% | – |
| Q3 2013 | $6,000 | +20.0% | 4,741 | +6.5% | 0.00% | – |
| Q2 2013 | $5,000 | – | 4,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tappan Street Partners LLC | 11,593,530 | $7,049,000 | 20.61% |
| Bandera Partners LLC | 1,421,000 | $864,000 | 0.78% |
| Brown Advisory Securities, LLC | 580,000 | $353,000 | 0.08% |
| Sterling Global Strategies LLC | 20,000 | $12,000 | 0.06% |
| Freedom Investment Management, Inc. | 1,052,770 | $642,000 | 0.04% |
| BAXTER BROS INC | 150,500 | $92,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 576,897 | $351,000 | 0.01% |
| Ballentine Partners, LLC | 25,001 | $113,000 | 0.01% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 57,700 | $37,000 | 0.01% |
| Spark Investment Management LLC | 128,600 | $78,000 | 0.01% |